🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Ganglioneuroblastoma

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma NCT06172296Phase 3180 sites📍 Birmingham📍 Mobile📍 Mesa National Cancer Institute (NCI) · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Carboplatin, Cisplatin International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE NCT03088020n/a1 site📍 Chicago Ilya Khaytin Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse NCT07437963Phase 1, Phase 22 sites📍 Oakland📍 Chicago National Cancer Institute (NCI) · Tests: Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography, Cyclophosphamide, Dinutuximab Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification NCT06296732n/a1 site📍 Moscow Federal Research Institute of Pediatric Hematology, Oncolog… · Tests: Duration of surgery intervention Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma NCT07502287Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: EB-DTNB-NK, Fludarabine, Cyclophosphamide Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma NCT07375563Phase 31 site📍 Moscow Federal Research Institute of Pediatric Hematology, Oncolog… · Tests: Dinutuximab beta, temozolomide, irinotecan, autologous NK cell, irinotecan, temozolomide, dinutuximab beta, NK-cell pro… Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) NCT03126916Phase 3164 sites📍 Birmingham📍 Phoenix📍 Little Rock Children's Oncology Group · Tests: Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration and Biopsy, Busulfan… Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma NCT06071897Phase 31 site📍 Moscow Federal Research Institute of Pediatric Hematology, Oncolog… · Tests: monoclonal antibodies GD2 SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours NCT05192980NA38 sites📍 Prague📍 Amiens📍 Angers Institut Curie · Tests: No Intervention NA
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy